Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer-Reference-Cited by-同舟云学术

Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer

Published:2020-02-18 Issue:12 Volume:38 Page:3177-3182
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Krajewski Wojciech,Rodríguez Faba Oscar,Breda Alberto,Pisano Francesca,Poletajew Sławomir,Tukiendorf Andrzej,Zdrojowy Romuald,Kołodziej Anna,Palou Juan

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-020-03130-1.pdf

Reference15 articles.

1. Babjuk M, Bohle A, Burger M et al (2017) eau guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461. https://doi.org/10.1016/j.eururo.2016.05.041

2. Shintani Y, Sawada Y, Inagaki T et al (2007) Intravesical instillation therapy with bacillus Calmette–Guerin for superficial bladder cancer: study of the mechanism of bacillus Calmette–Guerin immunotherapy. Int J Urol 14:140–146. https://doi.org/10.1111/j.1442-2042.2007.01696.x

3. DeVeale B, Brummel T, Seroude L (2004) Immunity and aging: the enemy within? Aging Cell 3:195–208. https://doi.org/10.1111/j.1474-9728.2004.00106.x

4. Pfister G, Savino W (2008) Can the immune system still be efficient in the elderly? An immunological and immunoendocrine therapeutic perspective. NeuroImmunoModulation 15:351–364. https://doi.org/10.1159/000156477

5. Herr HW (2007) Age and outcome of superficial bladder cancer treated with bacille Calmette–Guerin therapy. Urology 70:65–68. https://doi.org/10.1016/j.urology.2007.03.024

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Age with Non–muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?;European Urology Oncology;2024-02

2. Comparison of Bacillus Calmette-Guérin Maintenance Therapy with Monthly Instillations and the Southwest Oncology Group Protocol in the Treatment of Non–muscle-invasive Bladder Cancer;European Urology Focus;2023-11

3. Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006–2018: Effect of race, age and socioeconomic status on treatment disparities;Urologic Oncology: Seminars and Original Investigations;2023-10

4. Impact of age >70 years on oncological outcomes in patients with non‐muscle‐invasive bladder cancer treated with Bacillus Calmette–Guérin;BJU International;2023-08-02

5. Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Guérin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG;Urology;2022-09